Ind-Swift Laboratories is locked in upper circuit for the second straight day, up 10% at Rs 67.30, extending its six-session rally of over 60% on hopes of debt settlement.
The stock is trading at its 52-week high, zooming 83% in past seven trading sessions from Rs 36.80 on December 14, 2017. On comparison, the S&P BSE Sensex was up 2% during the same period.
The pharmaceutical company today said the company is in process of settlement of its debt through restructuring or OTS (one-time-settlement).
“We are at an advanced stage of the settlement with the Banks and
The stock is trading at its 52-week high, zooming 83% in past seven trading sessions from Rs 36.80 on December 14, 2017. On comparison, the S&P BSE Sensex was up 2% during the same period.
The pharmaceutical company today said the company is in process of settlement of its debt through restructuring or OTS (one-time-settlement).
“We are at an advanced stage of the settlement with the Banks and